Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Longpré

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|June 9, 2004
Identification of prodomain determinants involved in ADAMTS-1 biosynthesisJean-Michel Longpré, Richard Leduc
FEBS Letters|March 29, 2006
Inhibition of human matriptase by eglin c variantsAntoine Désilets, Jean-Michel Longpré, Marie-Eve Beaulieu, et al.
Protein Science : a Publication of the Protein Society|January 22, 2005
Stability of mutant serpin/furin complexes: dependence on pH and regulation at the deacylation stepErick K Dufour, Antoine Désilets, Jean-Michel Longpré, et al.
The Biochemical Journal|January 27, 2004
Identification of furin pro-region determinants involved in folding and activationLyne Bissonnette, Gabriel Charest, Jean-Michel Longpré, et al.
Biopolymers|April 15, 2014
Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluidAlexandre Murza, Karine Belleville, Jean-Michel Longpré, et al.
Bio-Protocol|March 4, 2021
Assessing Gα<sub>q/15</sub>-signaling with IP-One: Single Plate Transfection and Assay Protocol for Cell-Based High-Throughput AssayÉlie Besserer-Offroy, Rebecca L Brouillette, Jean-Michel Longpré, et al.
European Journal of Pharmacology|February 2, 2019
The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratioEmilie Eiselt, Jérôme Côté, Jean-Michel Longpré, et al.
Journal of Medicinal Chemistry|February 4, 2021
Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid AnalgesicMagali Chartier, Michael Desgagné, Marc Sousbie, et al.
The International Journal of Biochemistry & Cell Biology|November 11, 2008
Characterization of proADAMTS5 processing by proprotein convertasesJean-Michel Longpré, Daniel R McCulloch, Bon-Hun Koo, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
In Search of the Optimal Macrocyclization Site for NeurotensinMarc Sousbie, Élie Besserer-Offroy, Rebecca L Brouillette, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|June 9, 2004
Identification of prodomain determinants involved in ADAMTS-1 biosynthesisJean-Michel Longpré, Richard Leduc
FEBS Letters|March 29, 2006
Inhibition of human matriptase by eglin c variantsAntoine Désilets, Jean-Michel Longpré, Marie-Eve Beaulieu, et al.
Protein Science : a Publication of the Protein Society|January 22, 2005
Stability of mutant serpin/furin complexes: dependence on pH and regulation at the deacylation stepErick K Dufour, Antoine Désilets, Jean-Michel Longpré, et al.
The Biochemical Journal|January 27, 2004
Identification of furin pro-region determinants involved in folding and activationLyne Bissonnette, Gabriel Charest, Jean-Michel Longpré, et al.
Biopolymers|April 15, 2014
Stability and degradation patterns of chemically modified analogs of apelin-13 in plasma and cerebrospinal fluidAlexandre Murza, Karine Belleville, Jean-Michel Longpré, et al.
Bio-Protocol|March 4, 2021
Assessing Gα<sub>q/15</sub>-signaling with IP-One: Single Plate Transfection and Assay Protocol for Cell-Based High-Throughput AssayÉlie Besserer-Offroy, Rebecca L Brouillette, Jean-Michel Longpré, et al.
European Journal of Pharmacology|February 2, 2019
The combination of opioid and neurotensin receptor agonists improves their analgesic/adverse effect ratioEmilie Eiselt, Jérôme Côté, Jean-Michel Longpré, et al.
Journal of Medicinal Chemistry|February 4, 2021
Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid AnalgesicMagali Chartier, Michael Desgagné, Marc Sousbie, et al.
The International Journal of Biochemistry & Cell Biology|November 11, 2008
Characterization of proADAMTS5 processing by proprotein convertasesJean-Michel Longpré, Daniel R McCulloch, Bon-Hun Koo, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
In Search of the Optimal Macrocyclization Site for NeurotensinMarc Sousbie, Élie Besserer-Offroy, Rebecca L Brouillette, et al.
Pageof 6